Plasma microRNA, a potential biomarker for acute rejection after liver transplantation

Transplantation

Volumn 95, Issue 8, 2013, Pages 991-999

  Hu, Jie ^a   Wang, Zheng ^a   Tan, Chang Jun ^a   Liao, Bo Yi ^a   Zhang, Xin ^a   Xu, Min ^a   Dai, Zhi ^a   Qiu, Shuang Jian ^a   Huang, Xiao Wu ^a   Sun, Jian ^a   Sun, Qi Man ^a   He, Yi Feng ^a   Song, Kang ^a   Pan, Qi ^a   Wu, Ying ^a   Fan, Jia ^a   Zhou, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute rejection; Liver transplantation; MicroRNAs; Plasma; Rat model

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 122; MICRORNA 146A; MICRORNA 192; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG-INDUCED LIVER DAMAGE; IN SITU HYBRIDIZATION; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; LYMPHOCYTE; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED LEW; REAL-TIME POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876678114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31828618d8     Document Type: Article

References (35)

1. Morris PJ. TransplantationVa medical miracle of the 20th century. N Engl J Med 2004; 351: 2678.
2. Sayegh MH, Carpenter CB. Transplantation 50 years laterVprogress, challenges, and promises.N Engl J Med 2004; 351: 2761.
3. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365.
4. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006; 5: 77.
5. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106: 5330.
6. Anglicheau D, Suthanthiran M. Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 2008; 86:192.
7. Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010; 15: 35.
8. Ruvkun G. The perfect storm of tiny RNAs. Nat Med 2008; 14: 1041.
9. Tang G, Tang X, Mendu V, et al. The art of microRNA: various strategies leading to gene silencing via an ancient pathway. Biochim Biophys Acta 2008; 1779:655.
10. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009; 136: 26.
11. Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402.
12. Starkey Lewis PJ, Neoptolemos JP, Moggs J, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011; 54: 1767.
13. Shaked A, Ghobrial RM, Merion RM, et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 2009; 9: 301.
14. Ason B, Darnell DK, Wittbrodt B, et al. Differences in vertebrate microRNA expression. Proc Natl Acad Sci USA 2006; 103: 14385.
15. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue specific microRNAs from mouse. Curr Biol 2002; 12: 735.
16. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513.
17. Laterza OF, Lim L, Garrett-Engele PW, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977.
18. Sotolongo B, Asaoka T, Island E, et al. Gene expression profiling of microRNAs in small-bowel transplantation paraffin-embedded mucosal biopsy tissue. Transplant Proc 2010; 42: 62.
19. Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012; 18: 290.
20. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232.
21. Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830.
22. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481.
23. Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208: 1189.
24. Curtale G, Citarella F, Carissimi C, et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010; 115: 265.
25. Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142: 914.
26. + cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transpl Immunol 2010; 22: 165.
27. Asaoka T, Island ER, Tryphonopoulos P, et al. Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin embedded mucosal biopsies. Transpl Int 2011; 24: 697.
28. Yoshimura N, Ohsaka Y, Hamashima T, et al. Immunological study of unresponsive state in rat hepatic transplant model. 2. Immunosuppressive factor in the serum from the tolerant hosts. Eur Surg Res 1997; 29: 116.
29. Cocucci E, Racchetti G, Rupnik M, et al. The regulated exocytosis of enlargeosomes is mediated by a SNARE machinery that includes VAMP4. J Cell Sci 2008; 121: 2983.
30. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569.
31. Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 6: 654.
32. Fleissner F, Goerzig Y, Haverich A, et al. Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant 2012; 12: 289.
33. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: e3694.
34. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
35. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658.